Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last hours
Enjoy this offer
* See conditions under "Our services"

Valuation: PFIZER

Market Cap 148B 148B 128B 118B 111B 208B 14,032B 210B 1,392B 542B 6,871B 557B 545B 23,813B P/E Ratio 2026 *
12.2x
P/E Ratio 2027 * 12.9x
Enterprise Value 197B 197B 170B 156B 147B 275B 18,596B 278B 1,844B 719B 9,107B 738B 722B 31,559B EV / Sales 2026 *
3.19x
EV / Sales 2027 * 3.21x
Free-Float
59.05%
Yield 2026 *
6.73%
Yield 2027 * 6.7%
Manager TitleAgeSince
Chief Executive Officer 64 2018-12-31
Director of Finance/CFO 61 2022-05-01
Chief Tech/Sci/R&D Officer - 2006-12-31
Director TitleAgeSince
Director/Board Member 68 2007-08-31
Director/Board Member 62 2013-09-26
Chairman 64 2019-12-31
Change 5-day change 1-year change 3-year change Capi.($)
-0.61%-1.94%+39.00%+150.72% 1,001B
-0.20%-0.77%+51.51%+43.20% 566B
+0.40%-1.31%+16.56%+60.47% 393B
+0.37%+2.29%+24.04%+16.53% 326B
+0.06%+0.67%+25.39%+31.91% 276B
+0.47%-0.94%+25.10%+14.53% 277B
+2.10%+0.85%-41.50%-47.27% 193B
-0.77%+0.95%+17.69%+51.46% 188B
+2.36%+1.38%+14.80%+61.34% 158B
Average +0.77%+0.35%+19.18%+42.54% 375.2B
Weighted average by Cap. +0.61%-0.41%+27.88%+67.38%

Financials

2026 *2027 *
Net sales 61.69B 61.69B 53.16B 48.96B 45.97B 86.3B 5,833B 87.21B 578B 225B 2,856B 232B 227B 9,898B 59.32B 59.32B 51.12B 47.08B 44.2B 82.99B 5,609B 83.87B 556B 217B 2,747B 223B 218B 9,519B
Net income 11.07B 11.07B 9.54B 8.78B 8.25B 15.49B 1,047B 15.65B 104B 40.44B 513B 41.54B 40.66B 1,776B 10.96B 10.96B 9.45B 8.7B 8.17B 15.33B 1,036B 15.49B 103B 40.04B 507B 41.13B 40.26B 1,759B
Net Debt 48.28B 48.28B 41.6B 38.31B 35.97B 67.54B 4,564B 68.25B 453B 176B 2,235B 181B 177B 7,746B 42.08B 42.08B 36.26B 33.39B 31.35B 58.86B 3,978B 59.48B 395B 154B 1,948B 158B 155B 6,751B
Logo PFIZER
Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows: - primary care products (47.4%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.; - specialty care products (26.2%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.; - oncology products (24.5%); - other (1.9%). The United States accounts for 60.8% of net sales.
Employees
-
Trader
Investor
Global
Quality
ESG MSCI
A
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!